Johnson & Johnson is tapping Apple and its Apple Watch smartwatch to assist study extra in regards to the heart.

Janssen Pharmaceutical Companies, a Johnson & Johnson subsidiary, is partnering with Apple to study atrial fibrillation (AFib) and the way wearable applied sciences, just like the Apple Watch, might help individuals determine AFib and deal with it earlier than a health disaster happens.

AFib is an irregular heartbeat rhythm and the main reason for stroke within the U.S. According to Janssen, as much as six million Americans have AFib and, as a result of the situation typically has no signs, sufferers might not study of it till they undergo a critical cardiac occasion, like a stroke or heart assault.

Janssen’s partnership with Apple, referred to as the Heartline study, is aimed toward detecting these unidentified AFib circumstances. It’ll additionally assist researchers decide whether or not know-how can be utilized to foretell cardiac occasions earlier than they happen, and in addition permit them to study heart health exterior of a medical atmosphere with real-world data.

The Heartline study will solely be accessible to sufferers 65 years or older, who’re each U.S. residents, and have Original Medicare protection. Study members within the study should additionally personal an iPhone 6s or later and agree handy over their Medicare claims knowledge to researchers.

One group of members will solely use a Heartline Study app on their iPhone or Apple Watch that gives common academic notifications, ideas, surveys about heart health and customarily bettering the organ’s functioning.

Another group of members might want to put on their very own Apple Watch throughout the study. The Apple Watch will frequently transmit the study members’ heart rhythms to the Heartline Study app, which is able to determine any suspected AFib rhythms and notify customers when that occurs.

The study will happen over three years, together with two years of “active engagement” with notifications and different academic content material transmitted to each participant, in addition to an extra 12 months of knowledge assortment. Researchers will then consider the info to see if carrying an Apple Watch and understanding heart health can decrease the incidence of cardiac occasions.

Apple’s partnership with Johnson & Johnson is a part of a broader healthcare push by Apple. Last 12 months, Apple launched the outcomes of a heart study it performed with Stanford University, and in September, introduced a brand new Research app for researchers to gather and share person knowledge, alongside with research about heart health, ladies’s health, and listening to.

Apple CEO Tim Cook has additionally talked extensively in regards to the function Apple and Apple Watch might play in bettering health outcomes. Last 12 months on the Time 100 Summit in New York, Cook mentioned Apple might finally be remembered as a healthcare firm.

“I do think there will be the day that we will look back and say that Apple’s greatest contribution to mankind was in health care,” Cook mentioned.

People inquisitive about taking part within the Heartline study can join right here.

More must-read tales from Fortune:

—Apple corrects for coronavirus to maintain subsequent iPhones on observe
—Did the ‘techlash’ kill Alphabet’s metropolis of the longer term?
—How know-how is altering how we volunteer
—Oracle and Google will face off in tech’s trial of the century
—A.I. is remodeling the job interview—and all the pieces after

Catch up with Data Sheet, Fortune’s day by day digest on the enterprise of tech.

No Comments
Comments to: Apple pushes deeper into health research with Johnson & Johnson heart study